SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech for less than cash value -- Ignore unavailable to you. Want to Upgrade?


To: rkrw who wrote (303)1/12/2008 11:40:24 AM
From: Gary Mohilner  Read Replies (1) | Respond to of 684
 
Here's a study and a stock everyone should know about. The study is for TNFerade in Pancreatic Cancer, the stock is GNVC.

cbs4denver.com

This company is trading for more than cash value, but is dirt cheap at under $2, it won't be there for long.

If you look over on the GNVC thread on Yahoo you'll see that the CFO of the company confirmed that the trial patient was on TNFerade.

Gary